Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Scopus BioPharma Inc. (SCPS)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Assets |
| Cash and equivalents | 0.4 | 1.4 | | 1.2 | 4.0 | 7.9 | 3.6 | 6.3 |
| Other current assets | 0.1 | 0.2 | | 0.5 | 0.6 | 0.2 | 0.4 | 0.5 |
| Total current assets | 0.5 | 1.6 | | 1.7 | 4.6 | 8.2 | 4.0 | 6.8 |
| Property, plant, and equipment, net | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total assets | 0.5 | 1.6 | | 1.7 | 4.6 | 8.2 | 4.0 | 6.8 |
| |
| Accrued expenses | 5.0 | 5.1 | | 4.2 | 4.3 | 3.3 | 1.4 | 0.8 |
| Current portion of long-term debt | 0.0 | 0.0 | | 0.0 | 0.0 | 0.0 | 0.0 | 2.8 |
| Current portion of long-term debt | | | | | | | | 2.8 |
| Other current liabilities | 6.0 | 4.2 | | 1.2 | 1.0 | 0.9 | 0.9 | 5.1 |
| Total current liabilities | 11.0 | 9.3 | | 5.5 | 5.2 | 4.2 | 2.2 | 8.8 |
| Total liabilities | 11.0 | 9.3 | | 5.5 | 5.2 | 4.2 | 2.2 | 8.8 |
| |
| Shareholders' equity [+] | -10.5 | -7.7 | | -3.8 | -0.6 | 4.0 | 1.8 | -2.0 |
| Paid-in capital | 48.6 | 48.5 | | 45.7 | 45.6 | 45.5 | 38.3 | 33.1 |
| Retained earnings | -58.1 | -55.5 | | -49.4 | -46.1 | -41.5 | -34.9 | -33.5 |
| Tangible shareholders' equity | -10.5 | -7.7 | | -3.8 | -0.6 | 4.0 | 1.8 | -2.0 |
|